Cue Biopharma, Inc.
CUE· Nasdaq
Released Aug 8, 2023, after the close
10-Q filed Aug 8, 2023, 39 days after period end · 0000950170-23-039770
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $1.38M | $26.00K | $2.74M | $1.08M |
| Net Income | -$13.19M | -$13.21M | -$10.28M | -$10.83M |
| EPS Diluted | -$0.29 |
Cue Biopharma, Inc. · CIK 1645460 · Engraved from SEC EDGAR
| -$0.37 |
| -$0.33 |
| -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.